You think this group controls the entire hospital network of New York state re what clinical trials might be run by a given hospital?:
"So this all started by easily seeing "no clinical trials" offered in NY for Bavituximab+Docetaxel in Sunrise Phase III and why?? ... connecting those BlackRock dots to NYU hospital networks and the resistance they naturally have against Peregrine/PS Targeting to advance and Lori/Laurence Fink... and now seeing Lori Fink is also Chair of Perlmutter Cancer Center Advisory Board.... so we shall see where this path leads....."